Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management 2022-09-01 19:30
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc. 2022-08-31 17:05
GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance 2022-08-31 08:33
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2022 2022-08-30 18:00
Kintor Announces 2022 Interim Results and Recent Business Update 2022-08-30 00:19
NEXT-GENERATION EGFR TKI H002 FROM REDCLOUD BIO COMPLETES FIRST DOSE IN NON-SMALL CELL LUNG CANCER 2022-08-29 19:30
Porton Advanced and Royaltech Announce Strategic Collaboration to Accelerate the Development of Bacterial Drugs and mRNA Drugs 2022-08-29 12:23
Sanyou Biopharmaceuticals and KangaBio established strategic collaboration to accelerate antibody drug development and innovation 2022-08-28 08:00
Ascentage Pharma Announces 2022 Interim Results 2022-08-27 00:47
First approval of Cadonilimab (PD-1/CTLA-4 bispecific) published in Drugs, a peer-reviewed medical journal 2022-08-26 20:00
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe 2022-08-25 19:25
111, Inc. Announces Second Quarter 2022 Unaudited Financial Results 2022-08-25 14:18
Alpha Biopharma Announces Completion of its EVEREST Phase II/III Clinical Study of Zorifertinib in Non-Small Cell Lung Cancer Patients with Central Nervous System Metastases 2022-08-25 10:00
Asieris Pharmaceuticals (688176.SH) Issued 2022 Semi-Annual Report: Accelerated Global Clinical Development and Progressive Implementation of Its Integrated Diagnosis-Treatment Commercialization Strategy 2022-08-25 00:46
CARsgen 2022 Interim Results: Innovative CAR T-cell Technologies and Robust Pipeline 2022-08-24 20:50
Jacobio Pharma Announces 2022 Interim Results 2022-08-24 00:32
I-Mab Announces Share Purchase Plans by the Company and the Senior Management 2022-08-23 21:13
AVELOS THERAPEUTICS ANNOUNCES $8 MILLON SERIES A FUNDING ROUND 2022-08-22 20:00
Biosion, Inc. Appoints Steven Knapp, Pharm.D. as Chief Regulatory & Quality Officer 2022-08-22 13:00
I-Mab to Report Business and Corporate Updates and Financial Results for the Six Months Ended June 30, 2022 on August 30, 2022 2022-08-19 21:00
1 69 70 71 72 73 165